Jim Cramer's 'Mad Money' Recap: Faith in the Market
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK (TheStreet) -- You have to have faith if you're going to invest in the stock market, Jim Cramer told his "Mad Money" viewers Tuesday. Investors need to believe the companies they invest in will deliver on their promises. Fortunately, for some companies believing is not hard at all.
That's certainly the case with Regeneron
Cramer also offered a tip of the hat to Google
When can faith go awry? Cramer said he was wrong to trust Timken
Executive Decision: Leonard Schleifer
For his "Executive Decision" segment, Cramer spoke with Leonard Schleifer, president and CEO of Regeneron, which today announced continued successes with its drug Eyelea as well as a promising pipeline that includes drugs for high cholesterol, arthritis and asthma among others.
Schleifer said that despite analysts' calls to the contrary, Eyelea has lots of room to grow thanks to favorable demographics, new geographies and, he hopes, new indications for the drug later in 2014. Regeneron is also making progress on its anti-cholesterol drug, for which the company hopes to file for approval early next year.
In addition, Regeneron is developing promising treatments for the epidemic of allergic diseases that are developing, as well as treatments for genetic ailments.